about
CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin.Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivoBovine lactoferricin P13 triggers ROS-mediated caspase-dependent apoptosis in SMMC7721 cells.Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts.The role of macrophages in obesity-driven chronic liver disease.CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells.Lysyl oxidase isoforms in gastric cancer.Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth.Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviorsPreclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma
P2860
Q26779818-B740D2DE-5422-47D2-87DF-C9F7E367E5CEQ33749030-EC4F1409-5447-437E-A8EB-E34597A6A2FDQ37109719-2DB03B31-7638-40FE-883C-2F74C3100EABQ37138893-DEECF76B-47E9-4D51-AC90-4F98E82E30ECQ37593933-6122AFC3-150E-4860-86E2-F08218E997F4Q37688142-E1FF57D6-72C2-451F-8DBB-EAEEE0F14434Q38544274-865764DF-5326-4660-8D12-C7EA5ED6AEA4Q38758810-F0240EC4-9430-4CF7-8ECD-A524135200CFQ38829381-8DB0C529-FAE8-4487-A585-FB6F703FBFDAQ38855159-245EFABA-008A-45C5-A682-C817E645CD28Q38937873-E44BB0F3-1285-47EA-9F93-30F174AF1D96Q39064350-07696088-87C4-4FB5-B165-CA5C41432A0BQ41549602-9DC3F5AC-87F2-4CEF-8011-60A66983DFFBQ41549930-6944BF50-6A68-496E-8AD5-116648A703D4Q52591520-C01D6809-FC10-4BD7-B458-990BE635C7D6Q57175457-B5A87EC0-CB99-4CC5-9776-BFEEC15BA0E0Q58556622-45CCFC3D-DB2A-4ACC-A253-C39DCB35B047
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting the tumor stroma in hepatocellular carcinoma.
@en
type
label
Targeting the tumor stroma in hepatocellular carcinoma.
@en
prefLabel
Targeting the tumor stroma in hepatocellular carcinoma.
@en
P2860
P356
P1476
Targeting the tumor stroma in hepatocellular carcinoma.
@en
P2093
Femke Heindryckx
Pär Gerwins
P2860
P304
P356
10.4254/WJH.V7.I2.165
P577
2015-02-01T00:00:00Z